Intrafraction verification of gated rapidarc by using beam-level kilovoltage X-ray images

Ruijiang Li, Edward Mok, Daniel T. Chang, Megan E Daly, Billy W. Loo, Maximilian Diehn, Quynh Thu Le, Albert Koong, Lei Xing

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Purpose: To verify the geometric accuracy of gated RapidArc treatment using kV images acquired during dose delivery. Methods and Materials: Twenty patients were treated using the gated RapidArc technique with a Varian TrueBeam STx linear accelerator. One to 7 metallic fiducial markers were implanted inside or near the tumor target before treatment simulation. For patient setup and treatment verification purposes, the internal target volume (ITV) was created, corresponding to each implanted marker. The gating signal was generated from the Real-time Position Management (RPM) system. At the beginning of each fraction, individualized respiratory gating amplitude thresholds were set based on fluoroscopic image guidance. During the treatment, we acquired kV images immediately before MV beam-on at every breathing cycle, using the on-board imaging system. After the treatment, all implanted markers were detected, and their 3-dimensional (3D) positions in the patient were estimated using software developed in-house. The distance from the marker to the corresponding ITV was calculated for each patient by averaging over all markers and all fractions. Results: The average 3D distance between the markers and their ITVs was 0.8 ± 0.5 mm (range, 0-1.7 mm) and was 2.1 ± 1.2 mm at the 95th percentile (range, 0-3.8 mm). On average, a left-right margin of 0.6 mm, an anterior-posterior margin of 0.8 mm, and a superior-inferior margin of 1.5 mm is required to account for 95% of the intrafraction uncertainty in RPM-based RapidArc gating. Conclusion: To our knowledge, this is the first clinical report of intrafraction verification of respiration-gated RapidArc treatment in stereotactic ablative radiation therapy. For some patients, the markers deviated significantly from the ITV by more than 2 mm at the beginning of the MV beam-on. This emphasizes the need for gating techniques with beam-on/-off controlled directly by the actual position of the tumor target instead of external surrogates such as RPM.

Original languageEnglish (US)
JournalInternational Journal of Radiation Oncology Biology Physics
Volume83
Issue number5
DOIs
StatePublished - Aug 1 2012
Externally publishedYes

Fingerprint

markers
X-Rays
Time Management
x rays
margins
Respiration
Therapeutics
Fiducial Markers
tumors
geometric accuracy
Particle Accelerators
management systems
respiration
linear accelerators
Uncertainty
breathing
Neoplasms
Radiotherapy
Software
radiation therapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Intrafraction verification of gated rapidarc by using beam-level kilovoltage X-ray images. / Li, Ruijiang; Mok, Edward; Chang, Daniel T.; Daly, Megan E; Loo, Billy W.; Diehn, Maximilian; Le, Quynh Thu; Koong, Albert; Xing, Lei.

In: International Journal of Radiation Oncology Biology Physics, Vol. 83, No. 5, 01.08.2012.

Research output: Contribution to journalArticle

Li, Ruijiang ; Mok, Edward ; Chang, Daniel T. ; Daly, Megan E ; Loo, Billy W. ; Diehn, Maximilian ; Le, Quynh Thu ; Koong, Albert ; Xing, Lei. / Intrafraction verification of gated rapidarc by using beam-level kilovoltage X-ray images. In: International Journal of Radiation Oncology Biology Physics. 2012 ; Vol. 83, No. 5.
@article{5813712d22474fe4b2a3323cadc34d85,
title = "Intrafraction verification of gated rapidarc by using beam-level kilovoltage X-ray images",
abstract = "Purpose: To verify the geometric accuracy of gated RapidArc treatment using kV images acquired during dose delivery. Methods and Materials: Twenty patients were treated using the gated RapidArc technique with a Varian TrueBeam STx linear accelerator. One to 7 metallic fiducial markers were implanted inside or near the tumor target before treatment simulation. For patient setup and treatment verification purposes, the internal target volume (ITV) was created, corresponding to each implanted marker. The gating signal was generated from the Real-time Position Management (RPM) system. At the beginning of each fraction, individualized respiratory gating amplitude thresholds were set based on fluoroscopic image guidance. During the treatment, we acquired kV images immediately before MV beam-on at every breathing cycle, using the on-board imaging system. After the treatment, all implanted markers were detected, and their 3-dimensional (3D) positions in the patient were estimated using software developed in-house. The distance from the marker to the corresponding ITV was calculated for each patient by averaging over all markers and all fractions. Results: The average 3D distance between the markers and their ITVs was 0.8 ± 0.5 mm (range, 0-1.7 mm) and was 2.1 ± 1.2 mm at the 95th percentile (range, 0-3.8 mm). On average, a left-right margin of 0.6 mm, an anterior-posterior margin of 0.8 mm, and a superior-inferior margin of 1.5 mm is required to account for 95{\%} of the intrafraction uncertainty in RPM-based RapidArc gating. Conclusion: To our knowledge, this is the first clinical report of intrafraction verification of respiration-gated RapidArc treatment in stereotactic ablative radiation therapy. For some patients, the markers deviated significantly from the ITV by more than 2 mm at the beginning of the MV beam-on. This emphasizes the need for gating techniques with beam-on/-off controlled directly by the actual position of the tumor target instead of external surrogates such as RPM.",
author = "Ruijiang Li and Edward Mok and Chang, {Daniel T.} and Daly, {Megan E} and Loo, {Billy W.} and Maximilian Diehn and Le, {Quynh Thu} and Albert Koong and Lei Xing",
year = "2012",
month = "8",
day = "1",
doi = "10.1016/j.ijrobp.2012.03.006",
language = "English (US)",
volume = "83",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Intrafraction verification of gated rapidarc by using beam-level kilovoltage X-ray images

AU - Li, Ruijiang

AU - Mok, Edward

AU - Chang, Daniel T.

AU - Daly, Megan E

AU - Loo, Billy W.

AU - Diehn, Maximilian

AU - Le, Quynh Thu

AU - Koong, Albert

AU - Xing, Lei

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Purpose: To verify the geometric accuracy of gated RapidArc treatment using kV images acquired during dose delivery. Methods and Materials: Twenty patients were treated using the gated RapidArc technique with a Varian TrueBeam STx linear accelerator. One to 7 metallic fiducial markers were implanted inside or near the tumor target before treatment simulation. For patient setup and treatment verification purposes, the internal target volume (ITV) was created, corresponding to each implanted marker. The gating signal was generated from the Real-time Position Management (RPM) system. At the beginning of each fraction, individualized respiratory gating amplitude thresholds were set based on fluoroscopic image guidance. During the treatment, we acquired kV images immediately before MV beam-on at every breathing cycle, using the on-board imaging system. After the treatment, all implanted markers were detected, and their 3-dimensional (3D) positions in the patient were estimated using software developed in-house. The distance from the marker to the corresponding ITV was calculated for each patient by averaging over all markers and all fractions. Results: The average 3D distance between the markers and their ITVs was 0.8 ± 0.5 mm (range, 0-1.7 mm) and was 2.1 ± 1.2 mm at the 95th percentile (range, 0-3.8 mm). On average, a left-right margin of 0.6 mm, an anterior-posterior margin of 0.8 mm, and a superior-inferior margin of 1.5 mm is required to account for 95% of the intrafraction uncertainty in RPM-based RapidArc gating. Conclusion: To our knowledge, this is the first clinical report of intrafraction verification of respiration-gated RapidArc treatment in stereotactic ablative radiation therapy. For some patients, the markers deviated significantly from the ITV by more than 2 mm at the beginning of the MV beam-on. This emphasizes the need for gating techniques with beam-on/-off controlled directly by the actual position of the tumor target instead of external surrogates such as RPM.

AB - Purpose: To verify the geometric accuracy of gated RapidArc treatment using kV images acquired during dose delivery. Methods and Materials: Twenty patients were treated using the gated RapidArc technique with a Varian TrueBeam STx linear accelerator. One to 7 metallic fiducial markers were implanted inside or near the tumor target before treatment simulation. For patient setup and treatment verification purposes, the internal target volume (ITV) was created, corresponding to each implanted marker. The gating signal was generated from the Real-time Position Management (RPM) system. At the beginning of each fraction, individualized respiratory gating amplitude thresholds were set based on fluoroscopic image guidance. During the treatment, we acquired kV images immediately before MV beam-on at every breathing cycle, using the on-board imaging system. After the treatment, all implanted markers were detected, and their 3-dimensional (3D) positions in the patient were estimated using software developed in-house. The distance from the marker to the corresponding ITV was calculated for each patient by averaging over all markers and all fractions. Results: The average 3D distance between the markers and their ITVs was 0.8 ± 0.5 mm (range, 0-1.7 mm) and was 2.1 ± 1.2 mm at the 95th percentile (range, 0-3.8 mm). On average, a left-right margin of 0.6 mm, an anterior-posterior margin of 0.8 mm, and a superior-inferior margin of 1.5 mm is required to account for 95% of the intrafraction uncertainty in RPM-based RapidArc gating. Conclusion: To our knowledge, this is the first clinical report of intrafraction verification of respiration-gated RapidArc treatment in stereotactic ablative radiation therapy. For some patients, the markers deviated significantly from the ITV by more than 2 mm at the beginning of the MV beam-on. This emphasizes the need for gating techniques with beam-on/-off controlled directly by the actual position of the tumor target instead of external surrogates such as RPM.

UR - http://www.scopus.com/inward/record.url?scp=84863626767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863626767&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2012.03.006

DO - 10.1016/j.ijrobp.2012.03.006

M3 - Article

VL - 83

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 5

ER -